Favor Osakwe
Psychiatric/Mental Health · Spokane, WANPI 1194248666
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.0% of the total across 186 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 17.9% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 186 payments — averaging $55.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Neuronetics, Inc.$1K
- Otsuka America Pharmaceutical, Inc.$1K
- Teva Pharmaceuticals USA, Inc.$879
- Johnson & Johnson$603
- GSK$581
- plus $4K from 25 others
What the payments were for
- Travel & lodging$8028%
- Food & beverage$9,43092%
- Education$150%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 43 | $1,831 |
| Neuronetics, Inc. | 3 | $1,498 |
| Otsuka America Pharmaceutical, Inc. | 37 | $1,111 |
| Teva Pharmaceuticals USA, Inc. | 13 | $879 |
| Johnson & Johnson | 9 | $603 |
| GSK | 5 | $581 |
| Alkermes, Inc. | 8 | $427 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $421 |
| Axsome Therapeutics, Inc. | 11 | $361 |
| Lundbeck LLC | 15 | $302 |
| Sanofi | 2 | $246 |
| Idorsia Pharmaceuticals US Inc | 4 | $173 |
| Amgen | 2 | $168 |
| Neurocrine Biosciences, Inc. | 2 | $147 |
| Jazz Pharmaceuticals Inc. | 1 | $126 |
| Mylan Specialty L.p. | 1 | $125 |
| Kowa Pharmaceuticals America, Inc. | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $124 |
| Kyowa Kirin, Inc. | 1 | $122 |
| Gilead | 1 | $116 |
| Biohaven Pharmaceuticals, Inc. | 1 | $112 |
| Boehringer Ingelheim | 1 | $108 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $104 |
| Dexcom, Inc. | 1 | $78 |
| Lemaitre Vascular, Inc. | 2 | $68 |
| Vapotherm Inc | 1 | $66 |
| Biogen | 1 | $61 |
| Coloplast | 1 | $56 |
| Supernus Pharmaceuticals, Inc. | 3 | $55 |
| Sunovion Pharmaceuticals Inc. | 1 | $30 |
| Tris Pharma Inc | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEUROSTAR TMS THERAPY SYSTEM$1,467
- LYBALVI$1,388
- VRAYLAR$1,181
- BEXSERO$367
- CAPLYTA$364
- AUSTEDO$249
- ABILIFY MAINTENA$242
- SPRAVATO$240
- UZEDY$225
- INVEGA SUSTENNA$211
- INVEGA TRINZA$211
- Austedo XR$133
- SUNOSI$126
- Yupelri$125
- ZORYVE$125
- DUPIXENT$124
- FABRAZYME$122
- AREXVY$121
- INGREZZA$119
- ABILIFY ASIMTUFII$117
How this compares
$10,248 in reported general payments places this provider in the 95th percentile of 931 psychiatric/mental health providers in Washington.
Other psychiatric/mental health in Spokane
- Dawn MasonSpokane$25K
- Colleen MooreSpokane$8K
- Nicholas GoodwinSpokane$5K
- Margaret KyakuwaSpokane$5K
- Kiira TietjenSpokane$5K
- Angela HamelSpokane$4K
- Angela CombsRichland$121K
- Ashley McGinnisAuburn$26K
- Courtney YantPuyallup$26K
- Jennifer WilsonYakima$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.